Related references
Note: Only part of the references are listed.Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19: a meta-analysis
Wen Wen et al.
ANNALS OF MEDICINE (2022)
Remdesivir induces persistent mitochondrial and structural damage in human induced pluripotent stem cell-derived cardiomyocytes
Maxwell Kwok et al.
CARDIOVASCULAR RESEARCH (2022)
Potential Cardiotoxic Effects of Remdesivir on Cardiovascular System: A Literature Review
Maryam Nabati et al.
CARDIOVASCULAR TOXICOLOGY (2022)
Cardiovascular events and safety outcomes associated with remdesivir using a World Health Organization international pharmacovigilance database
Se Yong Jung et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2022)
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
A. Jayk Bernal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
R. L. Gottlieb et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models
Mihaly Varadi et al.
NUCLEIC ACIDS RESEARCH (2022)
The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of published clinical trials and observational studies
Dang The Hung et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)
Pharmacokinetics and tissue distribution of remdesivir and its metabolites nucleotide monophosphate, nucleotide triphosphate, and nucleoside in mice
Wen-juan Hu et al.
ACTA PHARMACOLOGICA SINICA (2021)
Risk Assessment of Drug-Induced Long QT Syndrome for Some COVID-19 Repurposed Drugs
Veronique Michaud et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
Severe sinus bradycardia associated with Remdesivir in a child with severe SARS-CoV-2 infection
Maria Isabel Sanchez-Codez et al.
EUROPEAN JOURNAL OF PEDIATRICS (2021)
N6-methyladenosine (m6A) is an endogenous A3 adenosine receptor ligand
Akiko Ogawa et al.
MOLECULAR CELL (2021)
Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man
Leora Branfield Day et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2021)
Effect of COVID-19 medications on corrected QT interval and induction of torsade de pointes: Results of a multicenter national survey
Majid Haghjoo et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)
Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Interface-based design of the favipiravir-binding site in SARS-CoV-2 RNA-dependent RNA polymerase reveals mutations conferring resistance to chain termination
Aditya K. Padhi et al.
FEBS LETTERS (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
Comprehensive Cardiotoxicity Assessment of COVID-19 Treatments Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Shota Yanagida et al.
TOXICOLOGICAL SCIENCES (2021)
Adverse Cardiovascular Effects of Anti-COVID-19 Drugs
Dongling Liu et al.
FRONTIERS IN PHARMACOLOGY (2021)
jMorp updates in 2020: large enhancement of multi-omics data resources on the general Japanese population
Shu Tadaka et al.
NUCLEIC ACIDS RESEARCH (2021)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19
Minchen Chien et al.
JOURNAL OF PROTEOME RESEARCH (2020)
Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19
Meagan L. Adamsick et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
Egor P. Tchesnokov et al.
VIRUSES-BASEL (2019)
Lysolipid receptor cross-talk regulates lymphatic endothelial junctions in lymph nodes
Yu Hisano et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Novel insights into the role of urotensin II in cardiovascular disease
Joao Pereira-Castro et al.
DRUG DISCOVERY TODAY (2019)
The ProTide Prodrug Technology: Where Next?
Ashwag S. Alanazi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold
Katherine L. Seley-Radtke et al.
ANTIVIRAL RESEARCH (2018)
Human gingival fibroblast feeder cells promote maturation of induced pluripotent stem cells into cardiomyocytes
Yusuke Matsuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
MUSCLEMOTION: A Versatile Open Software Tool to Quantify Cardiomyocyte and Cardiac Muscle Contraction In Vitro and In Vivo
Luca Sala et al.
CIRCULATION RESEARCH (2018)
A simple antegrade perfusion method for isolating viable single cardiomyocytes from neonatal to aged mice
Mariko Omatsu-Kanbe et al.
PHYSIOLOGICAL REPORTS (2018)
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo(2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses
Dustin Siegel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes
Hiroyuki Ando et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2017)
The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features
Helene Castel et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
How Ligands Illuminate GPCR Molecular Pharmacology
Daniel Wacker et al.
CELL (2017)
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K. Warren et al.
NATURE (2016)
TRPC3 positively regulates reactive oxygen species driving maladaptive cardiac remodeling
Naoyuki Kitajima et al.
SCIENTIFIC REPORTS (2016)
AutoDockFR: Advances in Protein-Ligand Docking with Explicitly Specified Binding Site Flexibility
Pradeep Anand Ravindranath et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells to Cardiomyocytes A Methods Overview
Christine L. Mummery et al.
CIRCULATION RESEARCH (2012)
Strength of NH...S Hydrogen Bonds in Methionine Residues Revealed by Gas-Phase IR/UV Spectroscopy
Himansu S. Biswal et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2012)
TGFα shedding assay: an accurate and versatile method for detecting GPCR activation
Asuka Inoue et al.
NATURE METHODS (2012)
EGFR trans-activation by urotensin II receptor is mediated by β-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophy
Giovanni Esposito et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
Ligand-Supported Purification of the Urotensin-II Receptor
Ann T. Du et al.
MOLECULAR PHARMACOLOGY (2010)
T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
Yousuke Furuta et al.
ANTIVIRAL RESEARCH (2009)
Model of Excitation-Contraction Coupling of Rat Neonatal Ventricular Myocytes
Topi Korhonen et al.
BIOPHYSICAL JOURNAL (2009)
Impact of GPCRs in clinical medicine: Monogenic diseases, genetic variants and drug targets
Paul A. Insel et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
hERG potassium channels and cardiac arrhythmia
MC Sanguinetti et al.
NATURE (2006)
Adenosine receptors as therapeutic targets
KA Jacobson et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Mammalian G proteins and their cell type specific functions
N Wettschureck et al.
PHYSIOLOGICAL REVIEWS (2005)
Transduction of receptor signals by β-arrestins
RJ Leftowitz et al.
SCIENCE (2005)
Factors contributing to decreased protein stability when aspartic acid residues are in β-sheet regions
PR Pokkuluri et al.
PROTEIN SCIENCE (2002)
Congestive heart failure and expression of myocardial urotensin II
SA Douglas et al.
LANCET (2002)
Timing of new black box warnings and withdrawals for prescription medications
KE Lasser et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Gαi and Gαo are target proteins of reactive oxygen species
M Nishida et al.
NATURE (2000)